HighVista Strategies LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1335325) · Explore on the interactive board
HighVista Strategies LLC disclosed 147 US equity positions worth $438.6m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is DBC at 6.4% of the reported book, followed by ABVX, RVMD. The top ten holdings are 28.2% of the book, and the portfolio behaves like about 64 equal-weight positions. Versus the prior filing it opened 29 new positions, added to 50, reduced 64 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does HighVista Strategies LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 29 new, 50 added, 64 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | DBC INVESCO DB COMMDY INDX TRCK | 6.4% | $28.2m | 1,057,238 | 0% | held | |
| 2 | ABVX ABIVAX SA | Healthcare | 3.4% | $15.1m | 113,031 | -0% | held |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.9% | $12.5m | 66,983 | -3% | reduced |
| 4 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 2.6% | $11.4m | 242,884 | 31% | added |
| 5 | IMVT IMMUNOVANT INC | Healthcare | 2.4% | $10.7m | 277,873 | 23% | added |
| 6 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 2.3% | $10.1m | 30,210 | 15% | added |
| 7 | RLAY RELAY THERAPEUTICS INC | Healthcare | 2.2% | $9.5m | 506,235 | 20% | added |
| 8 | ALKS ALKERMES PLC | Healthcare | 2.1% | $9.4m | 179,256 | 145% | added |
| 9 | PCVX VAXCYTE INC | Healthcare | 2.0% | $8.7m | 149,739 | 20% | added |
| 10 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.9% | $8.1m | 260,070 | 150% | added |
| 11 | LQDA LIQUIDIA CORPORATION | Healthcare | 1.8% | $7.8m | 97,896 | -2% | reduced |
| 12 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.7% | $7.3m | 188,780 | -4% | reduced |
| 13 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.6% | $7.0m | 130,784 | 6% | added |
| 14 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.6% | $7.0m | 137,866 | 89% | added |
| 15 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 1.6% | $6.9m | 386,080 | 10% | added |
| 16 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 1.6% | $6.9m | 77,807 | -47% | reduced |
| 17 | LB PHARMACEUTICALS INC | 1.6% | $6.9m | 211,511 | 22% | added | |
| 18 | CYTK CYTOKINETICS INC | Healthcare | 1.5% | $6.6m | 78,003 | 33% | added |
| 19 | CCCC C4 THERAPEUTICS INC | Healthcare | 1.4% | $6.3m | 1,348,136 | – | new |
| 20 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.3% | $5.9m | 184,774 | 41% | added |
| 21 | ALMS ALUMIS INC | Healthcare | 1.3% | $5.6m | 199,968 | 77% | added |
| 22 | PHVS PHARVARIS N V | Healthcare | 1.3% | $5.5m | 160,494 | 64% | added |
| 23 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.2% | $5.5m | 87,060 | 66% | added |
| 24 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.2% | $5.3m | 371,120 | 2% | added |
| 25 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.1% | $5.0m | 51,125 | 44% | added |
| 26 | NRIX NURIX THERAPEUTICS INC | Healthcare | 1.1% | $4.9m | 203,739 | -10% | reduced |
| 27 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 1.1% | $4.9m | 20,183 | -1% | reduced |
| 28 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 1.1% | $4.9m | 86,233 | 137% | added |
| 29 | VERA VERA THERAPEUTICS INC | Healthcare | 1.0% | $4.5m | 105,907 | 53% | added |
| 30 | NVDA NVIDIA CORPORATION | Technology | 1.0% | $4.4m | 21,792 | -3% | reduced |
| 31 | GHRS GH RESEARCH PLC | Healthcare | 1.0% | $4.3m | 158,770 | -26% | reduced |
| 32 | PALI PALISADE BIO INC | Healthcare | 1.0% | $4.2m | 2,030,927 | 1% | added |
| 33 | ARGX ARGENX SE | Healthcare | 1.0% | $4.2m | 4,561 | -7% | reduced |
| 34 | MAZE MAZE THERAPEUTICS INC | Healthcare | 0.9% | $4.1m | 136,572 | 37% | added |
| 35 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.9% | $4.0m | 408,534 | -7% | reduced |
| 36 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.9% | $4.0m | 41,902 | -47% | reduced |
| 37 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $3.8m | 171,961 | -6% | reduced |
| 38 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 0.8% | $3.7m | 90,996 | -1% | reduced |
| 39 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 0.8% | $3.7m | 187,946 | -3% | reduced |
| 40 | INSM INSMED INC | Healthcare | 0.8% | $3.3m | 31,256 | 29% | added |
| 41 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.7% | $3.2m | 86,964 | -3% | reduced |
| 42 | AMZN AMAZON COM INC | Consumer Cyclical | 0.7% | $3.2m | 13,397 | -40% | reduced |
| 43 | IVA INVENTIVA SA | 0.7% | $3.1m | 831,442 | 35% | added | |
| 44 | TLN TALEN ENERGY CORP | Utilities | 0.7% | $3.1m | 8,148 | 161% | added |
| 45 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 0.7% | $3.1m | 445,799 | – | new |
| 46 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.7% | $3.0m | 24,460 | -28% | reduced |
| 47 | ERAS ERASCA INC | Healthcare | 0.7% | $2.9m | 160,328 | -11% | reduced |
| 48 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.7% | $2.9m | 159,885 | 19% | added |
| 49 | HPE HEWLETT PACKARD ENTERPRISE C | Technology | 0.6% | $2.7m | 59,081 | -34% | reduced |
| 50 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.5% | $2.3m | 86,085 | 84% | added |
What did HighVista Strategies LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| 430 TERNS PHARMACEUTICALS INC | 11.1% | $6.0m |
| NUVALENT INC | 10.7% | $5.8m |
| SLNOEUR SOLENO THERAPEUTICS INC | 10.2% | $5.5m |
| APGE APOGEE THERAPEUTICS INC | 5.6% | $3.0m |
| JAZZ JAZZ PHARMACEUTICALS PLC | 3.8% | $2.0m |
| NATL NCR ATLEOS CORPORATION | 3.2% | $1.7m |
| CLH CLEAN HARBORS INC | 2.9% | $1.6m |
| CRM SALESFORCE INC | 2.9% | $1.6m |
| XOMA ROYALTY CORPORATION | 2.7% | $1.5m |
| AVTR AVANTOR INC | 2.7% | $1.5m |
| ASND ASCENDIS PHARMA A/S | 2.4% | $1.3m |
| INTU INTUIT | 2.4% | $1.3m |
| BKNG BOOKING HOLDINGS INC | 2.2% | $1.2m |
| KRC KILROY REALTY CORP | 2.2% | $1.2m |
| EQT EQT CORP | 2.2% | $1.2m |
| PBR/A PETROLEO BRASILEIRO S A | 2.1% | $1.1m |
| WDAY WORKDAY INC | 2.0% | $1.1m |
| PTC PTC INC | 2.0% | $1.1m |
| GEV GE VERNOVA INC | 2.0% | $1.1m |
| AGX ARGAN INC | 1.9% | $1.0m |
| AMRZ AMRIZE LTD | 1.8% | $956.1k |
| RDDT REDDIT INC | 1.7% | $929.1k |
| MMM 3M CO | 1.7% | $893.2k |
| UNP UNION PAC CORP | 1.6% | $887.5k |
| CPNG COUPANG INC | 1.6% | $869.2k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 68.5% |
| Technology | 8.3% |
| Industrials | 5.0% |
| Financial Services | 2.5% |
| Utilities | 2.1% |
| Consumer Cyclical | 1.8% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is HighVista Strategies LLC's portfolio?
Across every quarter HighVista Strategies LLC has filed, its median largest position is 7.4% of the book and its median top-ten weight is 27.7%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 38.0 completed holding spells, the median lasted 1.0 quarters; 147.0 positions are still open and their final length is unknown.